PRINCETON, N.J., Mar. 16, 2015 – WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that its Western Institutional Review Board® (WIRB®) company has been certified to ISO 9001:2008 by BSI, confirming that it operates an excellent quality management system.
“WIRB and its sister IRB, Copernicus Group, are the only two IRBs to have met ISO quality management standards and to have received ISO 9001:2008 certification,” commented WCG Chairman and CEO Donald A. Deieso, Ph.D. “We are proud to have set a new high bar for quality management in ethical review.”
“At WCG, we are always looking for ways to increase efficiencies within the clinical research process while – most importantly – maintaining the highest standards of human subject protection,” added WCG Chief Compliance Officer David Forster, JD, MA, CIP. “Achieving ISO certification is a powerful indicator of our commitment to continuous improvement in all aspects of our operations.”
Todd VanderVen, president of BSI Americas, stated, “WIRB is to be congratulated for its achievement of certification to ISO 9001:2008. Given Copernicus Group IRB’s earlier certification, WIRB’s achievement sends a clear message of WCG’s commitment to quality and dedication to continual improvement.”
All ISO 9000 standards are based on a series of quality management principles. They require company leaders to establish clear goals and objectives for their quality management system and endeavor to get all their employees involved. Participating companies adopt a strong customer focus with employees aiming not just to meet customer expectations but to exceed them. They also take both a process- and systems-based management approach, and strive for continual improvement in their company’s overall performance, using internal audits to track progress.
ISO 9001:2008 is implemented by more than one million companies and organizations in more than 170 countries, according to ISO.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.